Skip to main content
TipRanks
Go Ultimate75% OFF

Sienna Biopharmaceuticals (SNNAQ) Stock Statistics & Valuation Metrics

71 Followers

Total Valuation

Sienna Biopharmaceuticals has a market cap or net worth of $31.00. The enterprise value is -$18.40T.

Market Cap
$31.00
Enterprise Value
-$18.40T

Share Statistics

Sienna Biopharmaceuticals has 30,908,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
30,908,000
Owned by Insiders
―
Owned by Institutions
7.44%

Financial Efficiency

Sienna Biopharmaceuticals’s return on equity (ROE) is -0.46 and return on invested capital (ROIC) is -92.02%.

Return on Equity (ROE)
-0.46
Return on Assets (ROA)
-0.68
Return on Invested Capital (ROIC)
-92.02%
Return on Capital Employed (ROCE)
-0.92
Revenue Per Employee
0
Profits Per Employee
-5.64M
Employee Count
13
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Sienna Biopharmaceuticals is -0.00. Sienna Biopharmaceuticals’s PEG ratio is -0.00.

PE Ratio
-0.00
PS Ratio
0.00
PB Ratio
0.00
Price to FCF
-0.00
Price to Operating Cash Flow
-0.00
PEG Ratio
-0.00

Income Statement

In the last 12 months, Sienna Biopharmaceuticals had revenue of 0 and earned -73.31M in profits. Earnings per share was -3.59.

Revenue
0
Gross Profit
-157.00K
Operating Income
-76.50M
Pretax Income
-73.47M
Net Income
-73.31M
EBITDA
-76.34M
Earnings Per Share (EPS)
-3.59

Cash Flow

In the last 12 months, operating cash flow was -54.63M and capital expenditures -10,000, giving a free cash flow of -54.64M billion.

Operating Cash Flow
-54.63M
Free Cash Flow
-54.64M
Free Cash Flow per Share
-3.02

Dividends & Yields

Sienna Biopharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-1997153.02%
Earnings Yield
-3585036.67%

Stock Price Statistics

Beta
-112.52
52-Week Price Change
0.00%
50-Day Moving Average
0.01
200-Day Moving Average
0.01
Relative Strength Index (RSI)
―
Average Volume (3m)
―

Financial Position

Sienna Biopharmaceuticals as a current ratio of 2.07, with Debt / Equity ratio of 18.90%

Current Ratio
2.07
Quick Ratio
2.07
Debt to Market Cap
0.63
Net Debt to EBITDA
0.24
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Sienna Biopharmaceuticals has paid -157.00K in taxes.

Income Tax
-157.00K
Effective Tax Rate
0.00

Enterprise Valuation

Sienna Biopharmaceuticals EV to EBITDA ratio is 0.24, with an EV/FCF ratio of 0.30.

EV to Sales
0.00
EV to EBITDA
0.24
EV to Free Cash Flow
0.30
EV to Operating Cash Flow
0.30

Balance Sheet

Sienna Biopharmaceuticals has $11.33M in cash and marketable securities with $0.00 in debt, giving a net cash position of $11.33M billion.

Cash & Marketable Securities
$11.33M
Total Debt
$0.00
Net Cash
$11.33M
Net Cash Per Share
$0.37
Tangible Book Value Per Share
-$0.01

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%